José Luis Casado

25PUBLICATIONS
18CO-AUTHORS
Central nervous systemInfectious diseasesRegenerative medicine (incl. stem cells)Gene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Apr 14, 2026
Neuropsychiatric Tolerability of Long-Acting Cabotegravir and Rilpivirine in People With HIV With Prior INSTI-Related CNS Toxicity: A Real-World Cohort Study.

Marta Rosas Cancio-Suárez, Ana Moreno, Santos Del Campo Terrón

|Mar 18, 2026
Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study.

José L Casado, Pilar Vizcarra, Isabel Izuzquiza

|Oct 03, 2025
From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV.

José L Casado, José L Blanco, Isabel Izuzquiza

|Aug 27, 2025
Long-Acting Cabotegravir and Rilpivirine in Patients With HIV With Solid Organ Transplantation: A Case Series.

Ana Moreno, Ruben Fernandez-Ibanez, Santos Del Campo

|Jun 27, 2025
Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution.

Eloisa Yuste, María J Ruiz-De-León, José L Casado

|Apr 13, 2023
Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors.

Cristina Saavedra, Alejandro Vallejo, Federico Longo

Pageof 5

Frequent Collaborators

9 joint publications

Pilar Vizcarra

7 joint publications

Alejandro Vallejo

4 joint publications

Ana Moreno

3 joint publications

Santiago Moreno